1-20 of 21
Levi A. Garraway
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer

Seth A. Wander, Ofir Cohen, Xueqian Gong, Gabriela N. Johnson, Jorge E. Buendia-Buendia, Maxwell R. Lloyd, Dewey Kim, Flora Luo, Pingping Mao, Karla Helvie, Kailey J. Kowalski, Utthara Nayar, Adrienne G. Waks, Stephen H. Parsons, Ricardo Martinez, Lacey M. Litchfield, Xiang S. Ye, Chunping Yu, Valerie M. Jansen, John R. Stille, Patricia S. Smith, Gerard J. Oakley, Quincy S. Chu, Gerald Batist, Melissa E. Hughes, Jill D. Kremer, Levi A. Garraway, Eric P. Winer, Sara M. Tolaney, Nancy U. Lin, Sean G. Buchanan, Nikhil Wagle
Journal: Cancer Discovery
Cancer Discov (2020) 10 (8): 1174–1193.
https://doi.org/10.1158/2159-8290.CD-19-1390
Published: 03 August 2020
View articletitled, The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer
Open the PDF for The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas

Ophélia Maertens, Ryan Kuzmickas, Haley E. Manchester, Chloe E. Emerson, Alessandra G. Gavin, Caroline J. Guild, Terence C. Wong, Thomas De Raedt, Christian Bowman-Colin, Elodie Hatchi, Levi A. Garraway, Keith T. Flaherty, Shailja Pathania, Stephen J. Elledge, Karen Cichowski
Journal: Cancer Discovery
Cancer Discov (2019) 9 (4): 526–545.
https://doi.org/10.1158/2159-8290.CD-18-0879
Published: 01 April 2019
View articletitled, MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
Open the PDF for MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas in another window
Includes: Supplementary data
Journal Articles

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda, Richard A. Moffitt, Arezou A. Ghazani, Mehlika Hazar-Rethinam, Srivatsan Raghavan, Jaegil Kim, Lauren K. Brais, Dorisanne Ragon, Marisa W. Welch, Emma Reilly, Devin McCabe, Lori Marini, Kristin Anderka, Karla Helvie, Nelly Oliver, Ana Babic, Annacarolina Da Silva, Brandon Nadres, Emily E. Van Seventer, Heather A. Shahzade, Joseph P. St. Pierre, Kelly P. Burke, Thomas Clancy, James M. Cleary, Leona A. Doyle, Kunal Jajoo, Nadine J. McCleary, Jeffrey A. Meyerhardt, Janet E. Murphy, Kimmie Ng, Anuj K. Patel, Kimberly Perez, Michael H. Rosenthal, Douglas A. Rubinson, Marvin Ryou, Geoffrey I. Shapiro, Ewa Sicinska, Stuart G. Silverman, Rebecca J. Nagy, Richard B. Lanman, Deborah Knoerzer, Dean J. Welsch, Matthew B. Yurgelun, Charles S. Fuchs, Levi A. Garraway, Gad Getz, Jason L. Hornick, Bruce E. Johnson, Matthew H. Kulke, Robert J. Mayer, Jeffrey W. Miller, Paul B. Shyn, David A. Tuveson, Nikhil Wagle, Jen Jen Yeh, William C. Hahn, Ryan B. Corcoran, Scott L. Carter, Brian M. Wolpin
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2018) 8 (9): 1096–1111.
https://doi.org/10.1158/2159-8290.CD-18-0275
Published: 04 September 2018
View articletitled, Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Open the PDF for Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine in another window
Includes: Supplementary data
Journal Articles

Genetic Mechanisms of Immune Evasion in Colorectal Cancer

Catherine S. Grasso, Marios Giannakis, Daniel K. Wells, Tsuyoshi Hamada, Xinmeng Jasmine Mu, Michael Quist, Jonathan A. Nowak, Reiko Nishihara, Zhi Rong Qian, Kentaro Inamura, Teppei Morikawa, Katsuhiko Nosho, Gabriel Abril-Rodriguez, Charles Connolly, Helena Escuin-Ordinas, Milan S. Geybels, William M. Grady, Li Hsu, Siwen Hu-Lieskovan, Jeroen R. Huyghe, Yeon Joo Kim, Paige Krystofinski, Mark D.M. Leiserson, Dennis J. Montoya, Brian B. Nadel, Matteo Pellegrini, Colin C. Pritchard, Cristina Puig-Saus, Elleanor H. Quist, Ben J. Raphael, Stephen J. Salipante, Daniel Sanghoon Shin, Eve Shinbrot, Brian Shirts, Sachet Shukla, Janet L. Stanford, Wei Sun, Jennifer Tsoi, Alexander Upfill-Brown, David A. Wheeler, Catherine J. Wu, Ming Yu, Syed H. Zaidi, Jesse M. Zaretsky, Stacey B. Gabriel, Eric S. Lander, Levi A. Garraway, Thomas J. Hudson, Charles S. Fuchs, Antoni Ribas, Shuji Ogino, Ulrike Peters
Journal: Cancer Discovery
Cancer Discov (2018) 8 (6): 730–749.
https://doi.org/10.1158/2159-8290.CD-17-1327
Published: 31 May 2018
View articletitled, Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Open the PDF for Genetic Mechanisms of Immune Evasion in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir R. Aref, Patrick H. Lizotte, Elena Ivanova, Susanna Stinson, Chensheng W. Zhou, Michaela Bowden, Jiehui Deng, Hongye Liu, Diana Miao, Meng Xiao He, William Walker, Gao Zhang, Tian Tian, Chaoran Cheng, Zhi Wei, Sangeetha Palakurthi, Mark Bittinger, Hans Vitzthum, Jong Wook Kim, Ashley Merlino, Max Quinn, Chandrasekar Venkataramani, Joshua A. Kaplan, Andrew Portell, Prafulla C. Gokhale, Bart Phillips, Alicia Smart, Asaf Rotem, Robert E. Jones, Lauren Keogh, Maria Anguiano, Lance Stapleton, Zhiheng Jia, Michal Barzily-Rokni, Israel Cañadas, Tran C. Thai, Marc R. Hammond, Raven Vlahos, Eric S. Wang, Hua Zhang, Shuai Li, Glenn J. Hanna, Wei Huang, Mai P. Hoang, Adriano Piris, Jean-Pierre Eliane, Anat O. Stemmer-Rachamimov, Lisa Cameron, Mei-Ju Su, Parin Shah, Benjamin Izar, Manisha Thakuria, Nicole R. LeBoeuf, Guilherme Rabinowits, Viswanath Gunda, Sareh Parangi, James M. Cleary, Brian C. Miller, Shunsuke Kitajima, Rohit Thummalapalli, Benchun Miao, Thanh U. Barbie, Vivek Sivathanu, Joshua Wong, William G. Richards, Raphael Bueno, Charles H. Yoon, Juan Miret, Meenhard Herlyn, Levi A. Garraway, Eliezer M. Van Allen, Gordon J. Freeman, Paul T. Kirschmeier, Jochen H. Lorch, Patrick A. Ott, F. Stephen Hodi, Keith T. Flaherty, Roger D. Kamm, Genevieve M. Boland, Kwok-Kin Wong, David Dornan, Cloud Peter Paweletz, David A. Barbie
Journal: Cancer Discovery
Cancer Discov (2018) 8 (2): 196–215.
https://doi.org/10.1158/2159-8290.CD-17-0833
Published: 04 February 2018
View articletitled, Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Open the PDF for Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids in another window
Includes: Multimedia, Supplementary data
Journal Articles

Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations

Franklin W. Huang, Juan Miguel Mosquera, Andrea Garofalo, Coyin Oh, Maria Baco, Ali Amin-Mansour, Bokang Rabasha, Samira Bahl, Stephanie A. Mullane, Brian D. Robinson, Saud Aldubayan, Francesca Khani, Beerinder Karir, Eejung Kim, Jeremy Chimene-Weiss, Matan Hofree, Alessandro Romanel, Joseph R. Osborne, Jong Wook Kim, Gissou Azabdaftari, Anna Woloszynska-Read, Karen Sfanos, Angelo M. De Marzo, Francesca Demichelis, Stacey Gabriel, Eliezer M. Van Allen, Jill Mesirov, Pablo Tamayo, Mark A. Rubin, Isaac J. Powell, Levi A. Garraway
Journal: Cancer Discovery
Cancer Discov (2017) 7 (9): 973–983.
https://doi.org/10.1158/2159-8290.CD-16-0960
Published: 31 August 2017
View articletitled, Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations
Open the PDF for Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations in another window
Includes: Supplementary data
Journal Articles

Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer

Xiuning Le, Rajee Antony, Pedram Razavi, Daniel J. Treacy, Flora Luo, Mahmoud Ghandi, Pau Castel, Maurizio Scaltriti, José Baselga, Levi A. Garraway
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (10): 1134–1147.
https://doi.org/10.1158/2159-8290.CD-16-0305
Published: 02 October 2016
View articletitled, Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Open the PDF for Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting

Andrew J. Aguirre, Robin M. Meyers, Barbara A. Weir, Francisca Vazquez, Cheng-Zhong Zhang, Uri Ben-David, April Cook, Gavin Ha, William F. Harrington, Mihir B. Doshi, Maria Kost-Alimova, Stanley Gill, Han Xu, Levi D. Ali, Guozhi Jiang, Sasha Pantel, Yenarae Lee, Amy Goodale, Andrew D. Cherniack, Coyin Oh, Gregory Kryukov, Glenn S. Cowley, Levi A. Garraway, Kimberly Stegmaier, Charles W. Roberts, Todd R. Golub, Matthew Meyerson, David E. Root, Aviad Tsherniak, William C. Hahn
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (8): 914–929.
https://doi.org/10.1158/2159-8290.CD-16-0154
Published: 01 August 2016
View articletitled, Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Open the PDF for Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting in another window
Includes: Supplementary data
Journal Articles

Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations

Leanne G. Ahronian, Erin M. Sennott, Eliezer M. Van Allen, Nikhil Wagle, Eunice L. Kwak, Jason E. Faris, Jason T. Godfrey, Koki Nishimura, Kerry D. Lynch, Craig H. Mermel, Elizabeth L. Lockerman, Anuj Kalsy, Joseph M. Gurski, Jr, Samira Bahl, Kristin Anderka, Lisa M. Green, Niall J. Lennon, Tiffany G. Huynh, Mari Mino-Kenudson, Gad Getz, Dora Dias-Santagata, A. John Iafrate, Jeffrey A. Engelman, Levi A. Garraway, Ryan B. Corcoran
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2015) 5 (4): 358–367.
https://doi.org/10.1158/2159-8290.CD-14-1518
Published: 05 April 2015
View articletitled, Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
Open the PDF for Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations in another window
Includes: Supplementary data
Journal Articles

Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

Eliezer M. Van Allen, Kent W. Mouw, Philip Kim, Gopa Iyer, Nikhil Wagle, Hikmat Al-Ahmadie, Cong Zhu, Irina Ostrovnaya, Gregory V. Kryukov, Kevin W. O'Connor, John Sfakianos, Ilana Garcia-Grossman, Jaegil Kim, Elizabeth A. Guancial, Richard Bambury, Samira Bahl, Namrata Gupta, Deborah Farlow, Angela Qu, Sabina Signoretti, Justine A. Barletta, Victor Reuter, Jesse Boehm, Michael Lawrence, Gad Getz, Philip Kantoff, Bernard H. Bochner, Toni K. Choueiri, Dean F. Bajorin, David B. Solit, Stacey Gabriel, Alan D'Andrea, Levi A. Garraway, Jonathan E. Rosenberg
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2014) 4 (10): 1140–1153.
https://doi.org/10.1158/2159-8290.CD-14-0623
Published: 30 September 2014
View articletitled, Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
Open the PDF for Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors

David J. Konieczkowski, Cory M. Johannessen, Omar Abudayyeh, Jong Wook Kim, Zachary A. Cooper, Adriano Piris, Dennie T. Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E. Fisher, Jill P. Mesirov, William C. Hahn, Keith T. Flaherty, Jennifer A. Wargo, Pablo Tamayo, Levi A. Garraway
Journal: Cancer Discovery
Cancer Discov (2014) 4 (7): 816–827.
https://doi.org/10.1158/2159-8290.CD-13-0424
Published: 06 July 2014
View articletitled, A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
Open the PDF for A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors in another window
Includes: Supplementary data
Journal Articles

Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib

Nikhil Wagle, Brian C. Grabiner, Eliezer M. Van Allen, Eran Hodis, Susanna Jacobus, Jeffrey G. Supko, Michelle Stewart, Toni K. Choueiri, Leena Gandhi, James M. Cleary, Aymen A. Elfiky, Mary Ellen Taplin, Edward C. Stack, Sabina Signoretti, Massimo Loda, Geoffrey I. Shapiro, David M. Sabatini, Eric S. Lander, Stacey B. Gabriel, Philip W. Kantoff, Levi A. Garraway, Jonathan E. Rosenberg
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2014) 4 (5): 546–553.
https://doi.org/10.1158/2159-8290.CD-13-0353
Published: 01 May 2014
View articletitled, Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
Open the PDF for Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib in another window
Includes: Supplementary data
Journal Articles

The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

Eliezer M. Van Allen, Nikhil Wagle, Antje Sucker, Daniel J. Treacy, Cory M. Johannessen, Eva M. Goetz, Chelsea S. Place, Amaro Taylor-Weiner, Steven Whittaker, Gregory V. Kryukov, Eran Hodis, Mara Rosenberg, Aaron McKenna, Kristian Cibulskis, Deborah Farlow, Lisa Zimmer, Uwe Hillen, Ralf Gutzmer, Simone M. Goldinger, Selma Ugurel, Helen J. Gogas, Friederike Egberts, Carola Berking, Uwe Trefzer, Carmen Loquai, Benjamin Weide, Jessica C. Hassel, Stacey B. Gabriel, Scott L. Carter, Gad Getz, Levi A. Garraway, Dirk Schadendorf
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2014) 4 (1): 94–109.
https://doi.org/10.1158/2159-8290.CD-13-0617
Published: 07 January 2014
View articletitled, The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Open the PDF for The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

Nikhil Wagle, Eliezer M. Van Allen, Daniel J. Treacy, Dennie T. Frederick, Zachary A. Cooper, Amaro Taylor-Weiner, Mara Rosenberg, Eva M. Goetz, Ryan J. Sullivan, Deborah N. Farlow, Dennis C. Friedrich, Kristin Anderka, Danielle Perrin, Cory M. Johannessen, Aaron McKenna, Kristian Cibulskis, Gregory Kryukov, Eran Hodis, Donald P. Lawrence, Sheila Fisher, Gad Getz, Stacey B. Gabriel, Scott L. Carter, Keith T. Flaherty, Jennifer A. Wargo, Levi A. Garraway
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2014) 4 (1): 61–68.
https://doi.org/10.1158/2159-8290.CD-13-0631
Published: 07 January 2014
View articletitled, MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Open the PDF for MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers

Daniel Hagerstrand, Alexander Tong, Steven E. Schumacher, Nina Ilic, Rhine R. Shen, Hiu Wing Cheung, Francisca Vazquez, Yashaswi Shrestha, So Young Kim, Andrew O. Giacomelli, Joseph Rosenbluh, Anna C. Schinzel, Nicole A. Spardy, David A. Barbie, Craig H. Mermel, Barbara A. Weir, Levi A. Garraway, Pablo Tamayo, Jill P. Mesirov, Rameen Beroukhim, William C. Hahn
Journal: Cancer Discovery
Cancer Discov (2013) 3 (9): 1044–1057.
https://doi.org/10.1158/2159-8290.CD-12-0592
Published: 09 September 2013
View articletitled, Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers
Open the PDF for Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers in another window
Includes: Supplementary data
Journal Articles

Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

Vivian W.Y. Lui, Matthew L. Hedberg, Hua Li, Bhavana S. Vangara, Kelsey Pendleton, Yan Zeng, Yiling Lu, Qiuhong Zhang, Yu Du, Breean R. Gilbert, Maria Freilino, Sam Sauerwein, Noah D. Peyser, Dong Xiao, Brenda Diergaarde, Lin Wang, Simion Chiosea, Raja Seethala, Jonas T. Johnson, Seungwon Kim, Umamaheswar Duvvuri, Robert L. Ferris, Marjorie Romkes, Tomoko Nukui, Patrick Kwok-Shing Ng, Levi A. Garraway, Peter S. Hammerman, Gordon B. Mills, Jennifer R. Grandis
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2013) 3 (7): 761–769.
https://doi.org/10.1158/2159-8290.CD-13-0103
Published: 10 July 2013
View articletitled, Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Open the PDF for Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers in another window
Includes: Supplementary data
Journal Articles

A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition

Steven R. Whittaker, Jean-Philippe Theurillat, Eliezer Van Allen, Nikhil Wagle, Jessica Hsiao, Glenn S. Cowley, Dirk Schadendorf, David E. Root, Levi A. Garraway
Journal: Cancer Discovery
Cancer Discov (2013) 3 (3): 350–362.
https://doi.org/10.1158/2159-8290.CD-12-0470
Published: 07 March 2013
View articletitled, A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
Open the PDF for A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition in another window
Includes: Supplementary data
Journal Articles

Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, Calixte S. Monast, Christine A. Pratilas, Joan Montero, Mohit Butaney, Takeshi Shimamura, Lynette Sholl, Elena V. Ivanova, Madhavi Tadi, Andrew Rogers, Claire Repellin, Marzia Capelletti, Ophélia Maertens, Eva M. Goetz, Anthony Letai, Levi A. Garraway, Matthew J. Lazzara, Neal Rosen, Nathanael S. Gray, Kwok-Kin Wong, Pasi A. Jänne
Journal: Cancer Discovery
Cancer Discov (2012) 2 (10): 934–947.
https://doi.org/10.1158/2159-8290.CD-12-0103
Published: 14 October 2012
View articletitled, Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
Open the PDF for Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Whole-Genome Sequencing and Cancer Therapy: Is Too Much Ever Enough?

Levi A. Garraway, José Baselga
Journal: Cancer Discovery
Cancer Discov (2012) 2 (9): 766–768.
https://doi.org/10.1158/2159-8290.CD-12-0359
Published: 10 September 2012
View articletitled, Whole-Genome Sequencing and Cancer Therapy: Is Too Much Ever Enough?
Open the PDF for Whole-Genome Sequencing and Cancer Therapy: Is Too Much Ever Enough? in another window
Journal Articles

Circumventing Cancer Drug Resistance in the Era of Personalized Medicine

Levi A. Garraway, Pasi A. Jänne
Journal: Cancer Discovery
Cancer Discov (2012) 2 (3): 214–226.
https://doi.org/10.1158/2159-8290.CD-12-0012
Published: 13 March 2012
View articletitled, Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Open the PDF for Circumventing Cancer Drug Resistance in the Era of Personalized Medicine in another window